Similar articles for PMID: 11874177

Year	Number of Results
1973	1
1980	1
1982	1
1984	1
1986	3
1987	1
1988	3
1989	1
1990	3
1991	2
1992	9
1993	7
1994	1
1995	9
1996	5
1997	8
1998	5
1999	18
2000	9
2001	8
2002	7
2003	3
2004	5
2005	11
2006	8
2007	2
2008	6
2009	4
2010	11
2011	10
2012	6
2013	6
2014	5
2015	4
2017	2
2018	5
2019	9
2020	8
2021	10
2022	3
2023	1
2024	0

1

Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.

Stahnke N, Keller E, Landy H; Serono Study Group. Stahnke N, et al. J Pediatr Endocrinol Metab. 2002 Feb;15(2):129-38. doi: 10.1515/jpem.2002.15.2.129. J Pediatr Endocrinol Metab. 2002. PMID: 11874177 Clinical Trial.

2

Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.

Zeger MP, Shah K, Kowal K, Cutler GB Jr, Kushner H, Ross JL. Zeger MP, et al. Horm Res Paediatr. 2011;75(1):38-46. doi: 10.1159/000317529. Epub 2010 Aug 20. Horm Res Paediatr. 2011. PMID: 20733274 Free PMC article. Clinical Trial.

3

Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.

Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J. Nilsson KO, et al. J Clin Endocrinol Metab. 1996 Feb;81(2):635-40. doi: 10.1210/jcem.81.2.8636281. J Clin Endocrinol Metab. 1996. PMID: 8636281

4

Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?

Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG. Joss EE, et al. Horm Res. 1997;47(3):102-9. doi: 10.1159/000185443. Horm Res. 1997. PMID: 9050948 Clinical Trial.

5

Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.

Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. Menke LA, et al. J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8. J Clin Endocrinol Metab. 2010. PMID: 20061421 Clinical Trial.

6

Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.

Haeusler G, Frisch H, Schmitt K, Blümel P, Plöchl E, Zachmann M, Waldhör T. Haeusler G, et al. Eur J Pediatr. 1995 Jun;154(6):437-44. doi: 10.1007/BF02029351. Eur J Pediatr. 1995. PMID: 7545577 Clinical Trial.

7

Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.

Bareille P, Massarano AA, Stanhope R. Bareille P, et al. Eur J Pediatr. 1997 May;156(5):358-62. doi: 10.1007/s004310050614. Eur J Pediatr. 1997. PMID: 9177976 Clinical Trial.

8

The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.

Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM. Menke LA, et al. J Voice. 2011 Sep;25(5):602-10. doi: 10.1016/j.jvoice.2010.06.002. Epub 2010 Oct 25. J Voice. 2011. PMID: 20971614 Clinical Trial.

9

Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.

Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. Rosenfeld RG, et al. J Pediatr. 1998 Feb;132(2):319-24. doi: 10.1016/s0022-3476(98)70452-4. J Pediatr. 1998. PMID: 9506648 Clinical Trial.

10

Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.

Cacciari E, Mazzanti L. Cacciari E, et al. J Clin Endocrinol Metab. 1999 Dec;84(12):4510-5. doi: 10.1210/jcem.84.12.6175. J Clin Endocrinol Metab. 1999. PMID: 10599710 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

211 results

Results by year